Foundation Fighting Blindness
Foundation Fighting Blindness
Add to My Podcasts
Episodes
About
Reviews
Promote
Opus Genetics Receives FDA Clearance to Launch Clinical Trial for Best1 Gene Therapy
2 minutes
Posted Aug 22, 2025 at 2:19 pm.
0:00
2:07
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
The Foundation funded earlier, proof-of-concept studies for the Best1 gene therapy and later launched Opus to develop several IRD gene therapies.
Previous
jCyte Launches New Phase 2 Clinical Trial for its Cell-Based RP Therapy
Next
Eye on the Cure Podcast | Episode 91: Dr. George Magrath
← See all 261 episodes of Foundation Fighting Blindness